Abstract
IN an effort to find a satisfactory agent for the topical treatment of ringworm and other superficial mycoses, many substances, including antibiotics, have been investigated in the past. Although high anti-fungal activity has often been demonstrated by tests in vitro, such compounds have given disappointing clinical results when applied topically, and it is now recognized that this is probably due to the inability of such substances to penetrate the keratin of skin, hair and nails to the site of dermatophyte activity. For this reason it has often been suggested that the eventual curative agent will be administered systemically. Wilson1 states that “the ideal anti-fungal drug even for superficial mycoses would seem to be one which could be safely administered internally in amounts sufficient to endow the cells eventually destined to produce keratin with the power to resist fungi completely, this power persisting as they become keratinized, and the drug thus exerting its effects from within outward”.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
